Concepedia

Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

David E. Cohn, Michael W. Sill, Joan L. Walker, David M. O’Malley, Christa Nagel, Teresa Rutledge, William H. Bradley, Debra L. Richardson, Katherine Moxley, Carol Aghajanian

Gynecologic Oncology · 2017 · 78 citations · 14 references

Open access

References

14

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

Marta Pàez‐Ribes, Elizabeth Allen, James Hudock et al. · Cancer Cell · 2009 · 2.3K citations · Full text

Medicine, Cancer Biology, Oncology +16

Discrete sequential boundaries for clinical trials

K. K. Gordon Lan, David L. DeMets · Biometrika · 1983 · 1.7K citations

Business, Biostatistics, Decision Sciences +10

Discrete Sequential Boundaries for Clinical Trials

K. K. Gordon Lan, David L. DeMets · Biometrika · 1983 · 1.7K citations

Business, Biostatistics, Decision Sciences +10

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Maurie Markman, John A. Blessing, Stephen C. Rubin et al. · Gynecologic Oncology · 2005 · 244 citations

Medicine, Oncology, Pharmacology +13

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma

Mary L. Gemignani, Alan C. Schlaerth, Faina Bogomolniy et al. · Gynecologic Oncology · 2003 · 213 citations

Medicine, Molecular Genetics, Oncology +14